Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Locke

Showing results (51-60 of 61) with videos related to

Pageof 7
Sort By:
Plos Pathogens|March 10, 2020
Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite proteinDavid Oyen, Jonathan L Torres, Phillip C Aoto, et al.
NPJ Vaccines|August 13, 2021
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoesRoos M de Jong, Lisette Meerstein-Kessel, Dari F Da, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Nature Communications|July 28, 2023
Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infectionGregory M Martin, Jonathan L Torres, Tossapol Pholcharee, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structure and functional diversity of antibodies targeting the <i>P. falciparum</i> circumsporozoite protein C-terminal domainRe'em Moskovitz, Iszac Burton, Nathan Beutler, et al.
The Lancet. Global Health|November 15, 2025
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 studyBirahim Pierre Ndiaye, Lucy Koech, Laina D Mercer, et al.
Plos Pathogens|March 28, 2022
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparumNathan Beutler, Tossapol Pholcharee, David Oyen, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
The Journal of Infectious Diseases|May 29, 2025
Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan AdultsNathanial K Copeland, Lucas Otieno, June Doryne Otieno, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
Pageof 7

Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Plos Pathogens|March 10, 2020
Structure and mechanism of monoclonal antibody binding to the junctional epitope of Plasmodium falciparum circumsporozoite proteinDavid Oyen, Jonathan L Torres, Phillip C Aoto, et al.
NPJ Vaccines|August 13, 2021
Monoclonal antibodies block transmission of genetically diverse Plasmodium falciparum strains to mosquitoesRoos M de Jong, Lisette Meerstein-Kessel, Dari F Da, et al.
Vaccine|February 6, 2023
Safety, tolerability, and immunogenicity of inactivated poliovirus vaccine with or without E.coli double mutant heat-labile toxin (dmLT) adjuvant in healthy adults; a phase 1 randomized studyRahsan Erdem, Ilse De Coster, Kanchanamala Withanage, et al.
Nature Communications|July 28, 2023
Affinity-matured homotypic interactions induce spectrum of PfCSP structures that influence protection from malaria infectionGregory M Martin, Jonathan L Torres, Tossapol Pholcharee, et al.
Biorxiv : the Preprint Server for Biology|June 22, 2026
Structure and functional diversity of antibodies targeting the <i>P. falciparum</i> circumsporozoite protein C-terminal domainRe'em Moskovitz, Iszac Burton, Nathan Beutler, et al.
The Lancet. Global Health|November 15, 2025
Safety and non-inferiority of multidose and single-dose vial formulations of EuTCV Vi-CRM197 versus Typbar TCV in healthy participants in Kenya and Senegal: a multicentre, observer-blind, randomised, phase 3 studyBirahim Pierre Ndiaye, Lucy Koech, Laina D Mercer, et al.
Plos Pathogens|March 28, 2022
A novel CSP C-terminal epitope targeted by an antibody with protective activity against Plasmodium falciparumNathan Beutler, Tossapol Pholcharee, David Oyen, et al.
Plos One|September 1, 2012
Mosquito feeding assays to determine the infectiousness of naturally infected Plasmodium falciparum gametocyte carriersTeun Bousema, Rhoel R Dinglasan, Isabelle Morlais, et al.
The Journal of Infectious Diseases|May 29, 2025
Efficacy of RTS,S/AS01E Only Seen in Baseline Parasitemic and Not Baseline Aparasitemic Plasmodium falciparum-Exposed, Drug-Treated Kenyan AdultsNathanial K Copeland, Lucas Otieno, June Doryne Otieno, et al.
NPJ Vaccines|July 3, 2026
Epitope-selective vaccine designs to elicit protective antibodies against the Plasmodium falciparum circumsporozoite proteinMohammad Naghizadeh, Yevel Flores-Garcia, Reem Moskovitz, et al.
Pageof 7